Neuman Aluminium (Amstetten)

What they make

1 input Neuman Aluminium (Amstetten) supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Did you know2024

  Neuman Aluminium's impact-extrusion aluminum slugs supply pharmaceutical MDI inhaler canister makers (Presspart, Pressteck), consumer aerosol can manufacturers, and aluminum collapsible tube producers from the same production facility in Amstetten, Austria — using the same aluminum alloys, the same impact-extrusion presses, and the same basic process. The pharmaceutical-grade slugs going into asthma inhalers and the commercial-grade slugs going into deodorant cans are made by the same type of machine, from the same primary aluminum input, with the key differences being purity specification and quality documentation. During an extreme supply shortage (as occurred briefly during 2020-2021 supply chain stress), the decision about which downstream market receives available slug output — pharmaceutical MDI production (critical for asthma patients) or consumer aerosol (deodorant, household products) — is made by Neuman's production planners, not any regulatory body or emergency management system. Inhaler canister and deodorant can supply share the same slug production bottleneck.

  Neuman Aluminium GmbH ↗

• Concentration2022

  The pharmaceutical-grade aluminum slug supply chain for MDI inhalers passes through a very small cluster of European producers — Neuman Aluminium (Amstetten, Austria), Tubex (Mortagne-au-Perche, France, now part of Trivium Packaging), and a handful of others. Austria and France supply the majority of pharmaceutical-quality aluminum slugs for the global MDI market. This geographic concentration means that a single disruptive event affecting Central European aluminum manufacturing — an extreme energy price spike, a European aluminum smelter curtailment cycle, or a major supply disruption at one of the few high-purity 1xxx-series aluminum rolling mills that supply the slug producers — would cascade through the global MDI inhaler supply chain within 9-12 months (the estimated lead time to replace qualified slug supply). The 2021-2022 European energy crisis, which caused multiple European aluminum smelters to curtail production, was effectively a close call for the asthma inhaler supply chain.

  Aluminium Insider ↗

• Origin2024

  Neuman Aluminium is based in Amstetten, Lower Austria — a region with deep roots in precision metal fabrication and engineering that supplied the Austro-Hungarian industrial base and later Austria's postwar manufacturing renaissance. Lower Austria's Mostviertel (cider quarter) region, where Amstetten sits, evolved from agricultural and forestry-based economy to precision manufacturing through the 20th century, producing specialized metal components for industrial, automotive, and packaging applications. Neuman's pharmaceutical slug specialization represents the highest value-add tier of aluminum packaging: producing raw material for the world's most medically critical pressurized aluminum package — the inhaler canister — from a small Austrian town that most pharmaceutical executives have never visited. Austria's high engineering standards (ISO, pharmaceutical GMP, and aerospace-grade quality systems co-evolved in the country's precision manufacturing sector) give Neuman pharmaceutical-grade credibility that lower-cost slug producers in Eastern Europe or Asia have struggled to match for drug regulatory submissions.

  Neuman Aluminium GmbH ↗